About IMU Biosciences
IMU Biosciences has developed proprietary platform technologies that generate and translate vast system-level immune data into actionable insights and tools to drive the development of precision medicines across a variety of diseases. Built on over a decade of research at King’s College London and the Francis Crick Institute, IMU leverages advanced immune profiling with proprietary AI and machine learning analytics to uncover novel clinical immune signatures. IMU continues to establish partnerships with leading pharma and biotech companies to advance disease diagnosis, optimise product selection, and improve patient stratification and monitoring - while also building its own pipeline of...
Leadership at IMU Biosciences
The team at the top of the org chart.
John Baker
Chief Executive Officer
27 reports
Jeremy Mason
Chief Information Officer
Per Ullberg
CTO
2 reports
Adam Laing
Co-founder, President & CSO
5 reports
Mario Cantero
Co-founder & COO
9 reports
Jason Brown
CBO
2 reports
Tom Hayday
Co-founder & Chief Research Officer (cro)
2 reports
Katie Gosling
Executive Assistant